First Iowa Patient Receives New Implantable Device for Bladder Control Management

Patients in Iowa now have access to a new, minimally invasive treatment option for overactive bladder, as The Iowa Clinic’s Dr. Stephanie Morgan becomes the first physician in the state to offer the Altaviva™ implant.

Approved by the U.S. Food and Drug Administration (FDA), the device is designed to treat urge urinary incontinence (UUI), a common condition affecting more than 16 million adults in the United States. Despite its prevalence, many patients delay seeking care due to limited treatment options or discomfort discussing symptoms.

Altaviva works by gently stimulating the tibial nerve near the ankle, helping restore communication between the brain and bladder. The small, discreet device is placed just under the skin during a quick outpatient procedure and can begin working immediately.

“This is a meaningful step forward for patients who have struggled to find relief,” said Dr. Morgan. “Bladder control issues can impact daily life in ways people don’t always talk about. Having a treatment that is minimally invasive and fits into a patient’s routine gives us an important new way to help.”

The procedure does not require sedation or radiation, allowing patients to return to daily activities quickly. Therapy is activated the same day and is designed for long-term use, with a battery life of up to 15 years. It offers a new option for patients who have not found success with conservative treatments such as behavioral therapy or medication.

As the first clinic in Iowa to offer this newly approved therapy, The Iowa Clinic continues to expand access to advanced, physician‑led care. Dr. Morgan, whose clinical focus includes caring for patients with overactive bladder and urge urinary incontinence, leads this effort and can assist patients in determining whether Altaviva may be an appropriate treatment option for their symptoms.